Serge Carrière

Co-Founder at Theratechnologies, Inc.

Serge Carrière

Serge Carrière

Co-Founder at Theratechnologies, Inc.

Overview
Career Highlights

Phoenix International Life Sciences, Inc.
MedTech Partners, Inc.
Theratechnologies, Inc.

RelSci Relationships

182

Number of Boards

4

Relationships
RelSci Relationships are individuals Serge Carrière likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Director at Medical Discovery Management Corp.

Relationship likelihood: Strong

Former Lecturer at Harvard University

Relationship likelihood: Strong

Director at Medicago USA, Inc.

Relationship likelihood: Strong

Vice Chairman at Kessler Foundation, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer at Virginia Commonwealth University Health System

Relationship likelihood: Strong

Professional at EndoCeutics, Inc.

Relationship likelihood: Strong

Co-Founder at MaRS Discovery District

Relationship likelihood: Strong

Chairman & President at Anderson Industries, Inc.

Relationship likelihood: Strong

Venture Partner at Lumira Capital Investment Management, Inc.

Relationship likelihood: Strong

Executive Director at CellAegis Devices Inc.

Relationship likelihood: Strong

Paths to Serge Carrière
Potential Connections via
Relationship Science
You
Serge Carrière
Co-Founder at Theratechnologies, Inc.
Career History
Scientific Director, North America
Prior

They are driven by the belief in the excellence of their profession. theirs is a research-based organization, fulfilling a basic need and dedicated to the future.

Vice President, Clinical Research
Prior

C.H. Robinson Freight Services Ltd. provides air and ocean freight services. Its services include NVOCC and customs broker services. The company was founded by J. William McInerney and Stephane D. Rambaud in 1979 is headquartered in Wood Dale, IL.

Director
2006 - 2009

Medical Discovery Management Corp. manages the Canadian Medical Discoveries Fund (CMDF), a venture capital fund focused on the health science sector including life sciences, biotechnology, diagnostics, medical devices, drug discovery and development, health care delivery services and e-health. The Fund invests in technologies and intellectual property that are significant in the global marketplace and focuses on businesses involved in the testing and development or production and commercialization stages of development which have significant potential for growth. CMDF seeks investments that will provide at least a 30% annualized return. Expected time horizon for a liquid market, merger or acquisition is 2 to 4 years

Boards & Committees
Director
Current

EndoCeutics, Inc. develops hormone therapies. It offers products for vulvovaginal atrophy-sexual dysfunction, treatment of hot flushes and loss of bone, breast cancer treatment, treatment of endometriosis, treatment of prostate cancer, and male hypogonadism. The company was founded on July 26, 2006 and is headquartered in Quebec, Canada.

Chairman
Prior - 2006

MTP generally invests in research and technologies at an early stage of development, even prior to a full evaluation of commercial potential. Selection criteria include the potential size of the market, the credibility and efforts of the principal investigators, the uniqueness of the discovery and the patentability of the discovery.Investments are made by MTP or cover costs relating to patenting, demonstration of proof-of-principle, prototype development and market analysis.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$100K - $500K
2009

The Université de Montréal is a public research university in Montreal, Quebec, Canada. The francophone institution comprises thirteen faculties, more than sixty departments and two affiliated schools: the École Polytechnique (School of Engineering) and HEC Montréal (School of Business). It offers more than 650 undergraduate programmes and graduate programmes.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Serge Carrière. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Serge Carrière's profile does not indicate a business or promotional relationship of any kind between RelSci and Serge Carrière.